mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
-0.048 |
0.3 |
mRNA |
XAV-939 |
GDSC1000 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
-0.029 |
0.3 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.3 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.3 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
0.038 |
0.3 |